Press
He
Weizmann Wonder Wander
Science news and culture
Search
echo t('Click') ?>
X
Menu
Home Page
Area of Research
Math & Computer Science
People
Space & Physics
Chemistry
Life Sciences
Environment
Science Teaching
Scientific Archaeology
Technology & Applications
The Campus
The Website
For Journalists
RSS Service
Subscribe to our monthly newsletter/press releases
He
Skip to Home
Skip to Search
Skip to Content
Skip to Contact us
Skip to Sitemap
Skip to Accessibility Statement
Press Releases
All Press Releases
Receive Press Releases
RSS
News
Top Stories
Subscribe to our Monthly Newsletter
Explore Topics
Math and Computer Science
Space and Physics
Chemistry
Life Sciences
Environment
More
Scientific Archaeology
Science Teaching
Technology & Applications
People and Events
Awards and Appointments
People
Events
Science on Tap
Conferences
On Campus
Art on Campus
All People and Events
Multimedia
The Beauty of Science
Videos and Lectures
Nano Comics
Around Campus
More
Publications
Special Issues
Blue Sky Research
Planting Knowledge
100 Milestones in Physics
Art on Campus
All Special Issues
Buildings on Campus
What the Tree Has
Weizmann International Magazine of Science and People
About
About the Weizmann Institute of Science
Facts and Figures
Dr. Chaim Weizmann
Visit the Weizmann Institute of Science
Follow Us
Are you a journalist?
Please sign up here for our press releases
Subscribe to our monthly newsletter:
First name
Last name
Email
*
Agreement
*
I agree to the
Terms of Use
and
Cookie & Privacy Policy
You are here
Home
>
News
> All Press Releases
Press Releases
Search
Choose Topic
Math & Computer Science
Space & Physics
Chemistry
Life Sciences
Environment
Technology & Applications
Choose Language
English
French
German
Portuguese
Spanish
Functional MRI Will Enable Non-Invasive Visualization of brain Cortical Columns
25.01.2000
Space & Physics
,
Brain & Behavior
,
Disease, Drugs & Diagnostics
,
Diagnostic Techniques and Drugs
The accomplishment by Minnesota scientists, based on information gathered through optical imaging techniques innovated by Weizmann Institute scientists, should bridge the gap between neurophysiology and psychology by providing detailed insight into sensory perception and higher cognitive functions
Blood Test For Schizophrenia
17.01.2000
Brain & Behavior
,
Immunology
,
Disease, Drugs & Diagnostics
A relatively simple blood test for diagnosing the mental illness schizophrenia has been proposed by researchers at the Weizmann Institute of Science. The study, conducted by Prof. Sara Fuchs and graduate student Tal Ilani of the Immunology Department, is to be published on January 16, in the Proceedings of the National Academy of Sciences, U.S.A.
New Understanding Of A Key Control Mechanism In The Brain
13.01.2000
Brain & Behavior
,
Disease, Drugs & Diagnostics
Weizmann Institute findings could provide new insights into a wide range of neurological disorders, including Alzheimer's disease, autism, and epilepsy
X-Rays May Show The Way To Better Alzheimer's Drugs
27.12.1999
Disease, Drugs & Diagnostics
Weizmann Institute scientists have elucidated the means by which a plant substance blocks a key brain enzyme involved in Alzheimer's disease.
Protein Teamwork Drives Damaged Cells To Self-Destruct
12.12.1999
Disease, Drugs & Diagnostics
Researchers at the Weizmann Institute of Science have recently deciphered part of the cellular events underlying apoptosis -- programmed cell death. Their findings, published in Nature earlier this summer, provide important insights into cancer pathologies and their potential cures.
Key Progress by Weizmann Scientists in the Race to Unravel Ribosomal Structure
07.12.1999
Biochemistry
A team of Weizmann Institute and Max-Planck Society scientists has determined the structure of the small ribosomal subunit at the highest resolution ever achieved, including the site where protein biosynthesis begins.
Progress Reported in Developing Compounds That Mimic Insulin for the Treatment of Type II Diabetes
24.11.1999
Disease, Drugs & Diagnostics
Diabetic patients suffer from a metabolic disorder in which the insulin hormone responsible for allowing the passage of energy rich nutrients from the bloodstream into the body's cells does not function properly or at all. Diabetes afflicts 15 million Americans, and 90 percent of these cases are classified as type II diabetes.
New Molecule Boosts Stem Cell Survival
01.08.1999
Disease, Drugs & Diagnostics
Weizmann Institute researchers have developed a molecule that allows blood stem cells - the body's most primitive, immature cells that originate in the bone marrow - to multiply without maturation in the test tube. This achievement, described in the August issue of the journal Blood, may improve bone marrow transplantation, in which stem cells are infused into a patient to replace defective or malignant marrow. The study may also advance gene therapy research.
Solar Technology Breakthrough
06.07.1999
Environment
An innovative solar power system was presented at the ISES congress. The system has been under development since 1996, within the framework of the US-Israel Science and Technology Foundation, by a consortium, which includes BOEING, ORMAT, and Rotem Industries in collaboration with the Weizmann Institute of Science. The initial technologies were developed within the solar consortium Consolar in the framework of MAGNET program of the Ministry of Industry and Trade.
DNA Crystals Help Bacteria Respond to Stress
01.07.1999
Biochemistry
DNA becomes remarkably organized in bacteria that are subjected to various conditions of stress, Weizmann Institute scientists reported in the July 1 issue of Nature. The tightly packed structure promotes the ability of the cells to withstand extreme environmental assaults such as oxidating agents and starvation.
Pages
« first
‹ previous
…
58
59
60
61
62
63
64
65
66
…
next ›
last »
Are you a journalist?
Please sign up here for our press releases
Most Popular Articles
One Protein, Two Programs
A cell’s decision to commit suicide involves an exchange of information between two suicide mechanisms
Israeli Researchers to Participate in European Commission Flagship
The European Commission has officially announced the selection of the Human Brain Project (HBP) as one of its two Future Emerging Technologies (FET) Flagship projects.
Checking the Dosage
Prof. Yoram Groner is a pioneer in Down syndrome research
Accessibility Toolbar
❌
+
Enlarge text
-
Reduce text
Monochrome
Contrast
Underline Links
Reset
Accessibility Statement